Parameter
| Biomarker | CA19-9 | Full name | Carbohydrate antigen 19-9 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Monitoring, prognosis | ||
| Disease | Colorectal Cancer (CRC) | Disease Subtypes | / | ||
| Organ | Colorectal | Test Sample / Technology Platform | Blood (ELISA, chemiluminescence immunoassay) | ||
| Pathobiological Mechanisms | It is highly expressed in colorectal cancer and other gastrointestinal tumors, and is related to tumor invasion and metastasis | ||||
| Clinical Availability Status | Clinically available (monitoring) : used for postoperative recurrence and treatment response monitoring of CRC, especially for patients with liver metastases | ||||
| Notes and Dynamics | Separately using diagnostic value is limited, and CEA joint can improve the sensitivity and specificity of CRC monitoring | ||||